ARVN
Price
$7.53
Change
+$0.61 (+8.82%)
Updated
Jun 6 closing price
Capitalization
549.63M
54 days until earnings call
KTTA
Price
$0.89
Change
+$0.01 (+1.14%)
Updated
Jun 6 closing price
Capitalization
6.59M
Interact to see
Advertisement

ARVN vs KTTA

Header iconARVN vs KTTA Comparison
Open Charts ARVN vs KTTABanner chart's image
Arvinas
Price$7.53
Change+$0.61 (+8.82%)
Volume$2.76M
Capitalization549.63M
Pasithea Therapeutics
Price$0.89
Change+$0.01 (+1.14%)
Volume$160.37K
Capitalization6.59M
ARVN vs KTTA Comparison Chart
Loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARVN vs. KTTA commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a StrongBuy and KTTA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (ARVN: $7.53 vs. KTTA: $0.89)
Brand notoriety: ARVN and KTTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARVN: 99% vs. KTTA: 2%
Market capitalization -- ARVN: $549.63M vs. KTTA: $6.59M
ARVN [@Biotechnology] is valued at $549.63M. KTTA’s [@Biotechnology] market capitalization is $6.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 2 FA rating(s) are green whileKTTA’s FA Score has 1 green FA rating(s).

  • ARVN’s FA Score: 2 green, 3 red.
  • KTTA’s FA Score: 1 green, 4 red.
According to our system of comparison, ARVN is a better buy in the long-term than KTTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 6 TA indicator(s) are bullish while KTTA’s TA Score has 5 bullish TA indicator(s).

  • ARVN’s TA Score: 6 bullish, 3 bearish.
  • KTTA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ARVN is a better buy in the short-term than KTTA.

Price Growth

ARVN (@Biotechnology) experienced а +4.58% price change this week, while KTTA (@Biotechnology) price change was -8.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

ARVN is expected to report earnings on Jul 31, 2025.

KTTA is expected to report earnings on Mar 24, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARVN($550M) has a higher market cap than KTTA($6.59M). ARVN YTD gains are higher at: -60.720 vs. KTTA (-71.879). KTTA has higher annual earnings (EBITDA): -15.49M vs. ARVN (-89.3M). ARVN has more cash in the bank: 954M vs. KTTA (9.36M). KTTA has less debt than ARVN: KTTA (0) vs ARVN (10.5M). ARVN has higher revenues than KTTA: ARVN (427M) vs KTTA (0).
ARVNKTTAARVN / KTTA
Capitalization550M6.59M8,341%
EBITDA-89.3M-15.49M576%
Gain YTD-60.720-71.87984%
P/E RatioN/AN/A-
Revenue427M0-
Total Cash954M9.36M10,191%
Total Debt10.5M0-
FUNDAMENTALS RATINGS
ARVN: Fundamental Ratings
ARVN
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
22
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARVNKTTA
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
80%
Bullish Trend 9 days ago
72%
Declines
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SQM32.760.46
+1.42%
Sociedad Quimica y Minera de Chile SA
IIPR55.340.56
+1.02%
Innovative Industrial Properties
MDV14.07-0.01
-0.07%
Modiv Industrial
AMBC7.39-0.17
-2.25%
Ambac Financial Group
AMST2.84-0.08
-2.74%
Amesite

ARVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARVN
1D Price
Change %
ARVN100%
+8.82%
AXON - ARVN
46%
Loosely correlated
+1.52%
VCYT - ARVN
46%
Loosely correlated
+1.78%
ERAS - ARVN
40%
Loosely correlated
+1.91%
ATXS - ARVN
40%
Loosely correlated
+14.75%
SRPT - ARVN
40%
Loosely correlated
+9.69%
More

KTTA and

Correlation & Price change

A.I.dvisor tells us that KTTA and FATE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KTTA and FATE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KTTA
1D Price
Change %
KTTA100%
+0.66%
FATE - KTTA
32%
Poorly correlated
+19.40%
ACET - KTTA
25%
Poorly correlated
+1.04%
TRAW - KTTA
24%
Poorly correlated
+11.49%
ARVN - KTTA
24%
Poorly correlated
+8.82%
MCRB - KTTA
23%
Poorly correlated
+13.36%
More